Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

adenocarcinoma

  • You have access
    Discrepancies Between Morphological and Immunohistochemical Classifications Are Associated With Prognoses and Subtypes of Lung Cancer
    KOSUKE NATSUME, JUANJUAN YE, YURI MUKAI, KEIKO YAMAKAWA, MISA TANIMOTO, HIROYUKI ITO, YOHEI MIYAGI, YATARO DAIGO, MARIKO MUTO-ISHIZUKA, KYUICHI KADOTA, REIJI HABA and FUTOSHI SUIZU
    Anticancer Research February 2024, 44 (2) 711-722; DOI: https://doi.org/10.21873/anticanres.16862
  • You have access
    (Pro)renin Receptor Down-regulation Is Associated With a Higher Risk of Recurrence in Lung Adenocarcinoma
    NACHINO KIMURA, KYUICHI KADOTA, EMI IBUKI, RYOU ISHIKAWA, TOSHIHIRO IKEDA, CHIHIRO YOSHIDA, TOSHIKI YAJIMA, AKIRA NISHIYAMA and REIJI HABA
    Anticancer Research December 2023, 43 (12) 5671-5680; DOI: https://doi.org/10.21873/anticanres.16772
  • Open Access
    Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy – An Update
    EWALD WÖLL, ARNO AMANN, WOLFGANG EISTERER, ARMIN GERGER, BIRGIT GRÜNBERGER, HOLGER RUMPOLD, LUKAS WEISS, THOMAS WINDER, RICHARD GREIL and GERALD W. PRAGER
    Anticancer Research July 2023, 43 (7) 2889-2897; DOI: https://doi.org/10.21873/anticanres.16460
  • You have access
    Clinical and Oncological Impact of the Toll-like Receptor-3 and -4 in Esophageal and Gastro-esophageal Junction Adenocarcinoma
    SPYRIDON DAVAKIS, ALKISTIS KAPELOUZOU, STRATIGOULA SAKELLARIOU, KONSTANTINOS G. KYRIAKOULIS, ADAM MYLONAKIS, STAVROS P. PAPADAKOS, MARIA MPOURA, MICHAIL VAILAS, DIMITRIOS ZIOGAS, THEODOROS LIAKAKOS and ALEXANDROS CHARALABOPOULOS
    Anticancer Research July 2023, 43 (7) 3183-3191; DOI: https://doi.org/10.21873/anticanres.16492
  • You have access
    Metastatic Adenocarcinoma of the Lung Presenting as a Presternal Cutaneous Mass: Case Report and Brief Literature Review
    HASNA KERROUCH, MARIE DANSET, NAOUFAL HJIRA and JEAN KANITAKIS
    Anticancer Research May 2023, 43 (5) 2367-2370; DOI: https://doi.org/10.21873/anticanres.16402
  • You have access
    Neoadjuvant Therapy for Patients With Non-small Cell Lung Cancer Complicated With Chest Wall Invasion
    KEIYU SATO, SHOTA NAKAMURA, YUKA KADOMATSU, HARUSHI UENO, TAKETO KATO, NAOKI OZEKI, KOICHI FUKUMOTO and TOYOFUMI FENGSHI CHEN-YOSHIKAWA
    Anticancer Research November 2022, 42 (11) 5539-5546; DOI: https://doi.org/10.21873/anticanres.16059
  • Open Access
    Comparison of Proportion of Elevated Carcinoembryonic Antigen Levels in Patients With Appendiceal and Colorectal Adenocarcinoma: A Systematic Review and Meta-analysis
    ADAM T. CRISTAUDO, SCOTT B. JENNINGS and DAVID L. MORRIS
    Anticancer Research September 2022, 42 (9) 4217-4235; DOI: https://doi.org/10.21873/anticanres.15922
  • Open Access
    The Role of Toll-like Receptors in Esophageal Cancer
    SPYRIDON DAVAKIS, ALKISTIS KAPELOUZOU, THEODOROS LIAKAKOS, MARIA MPOURA, DIMITRIOS STERGIOU, STRATIGOULA SAKELLARIOU and ALEXANDROS CHARALABOPOULOS
    Anticancer Research June 2022, 42 (6) 2813-2818; DOI: https://doi.org/10.21873/anticanres.15762
  • You have access
    Annexin A10 Expression as a Novel Prognostic Marker in Lung Adenocarcinoma
    MASAKO YUMURA, TATSUYA NAGANO, NAOE JIMBO, RYOTA DOKUNI, TATSUNORI KIRIU, YUGO TANAKA, MOTOKO TACHIHARA, TOMOO ITOH, YOSHIMASA MANIWA, YOSHIHIRO NISHIMURA and KAZUYUKI KOBAYASHI
    Anticancer Research March 2022, 42 (3) 1289-1294; DOI: https://doi.org/10.21873/anticanres.15595
  • You have access
    Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma
    NAOKI URAKAWA, SHINGO KANAJI, SATOSHI SUZUKI, RYUICHIRO SAWADA, HITOSHI HARADA, HIRONOBU GOTO, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, TAKERU MATSUDA, TARO OSHIKIRI and YOSHIHIRO KAKEJI
    Anticancer Research February 2022, 42 (2) 1051-1057; DOI: https://doi.org/10.21873/anticanres.15566

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire